berbamine

Independent reference data for berbamine (CAS 478-61-5), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Synonyms and trade names

BERBAMINE; (+)-Berbamine; 478-61-5; d-Berbamine; Berbenine; 6,6',7-Trimethoxy-2,2'-dimethylberbaman-12-ol; V5KM4XJ0WM; CCRIS 6538; NSC-121842; BRN 0078902; BERBAMINE, (+)-; DTXSID40963943; NSC121842; Berbaman-12-ol, 6,6',7-trimethoxy-2,2'-dimethyl-; berbamine, (+); RefChem:119034

What the public record says

berbamine · CAS 478-61-5 · C37H40N2O6. UNII V5KM4XJ0WM.

Source: PubChem / Wikidata; the batch COA governs where values differ.